Pharmaceuticals Ultrasector ProfundPHPSX
Type
Mutual fund
Peer group
Alternative
Net assets
$3.4M
Expense ratio
2.78%
1-year return
+55.9%
3 years, a year
+11.1%
5 years, a year
+5.5%
Holdings
70
What it aims to do.
Pharmaceuticals UltraSector ProFund (the Fund) seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) of the daily performance of the S&P Pharmaceuticals Select Industry Index (the Index).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| N/A | 7.30% |
| N/A | 6.23% |
| N/A | 5.49% |
| N/A | 3.62% |
| OGN Organon & Company | 2.73% |
| N/A | 2.11% |
| CORT Corcept Therapeutics Inc | 1.82% |
| ELVN Enliven Therapeutics Inc | 1.77% |
| AXSM Axsome Therapeutics Inc | 1.71% |
| OMER Omeros Corp | 1.61% |
More on PHPSX.
- PHPSX overview
- PHPSX holdings
- PHPSX risk
- PHPSX costs
- PHPSX money in and out
- PHPSX share classes
- Compare PHPSX with other funds
Returns after fees, from the fund's SEC filings up to Apr 2026. Past returns are not a promise. Not financial advice.